부산대학교 도서관

Salomon N; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University gGmbH, 55131 Mainz, Germany.; Vascotto F; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University gGmbH, 55131 Mainz, Germany.; Selmi A; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University gGmbH, 55131 Mainz, Germany.; Vormehr M; BioNTech SE, 55131 Mainz, Germany.; Quinkhardt J; BioNTech SE, 55131 Mainz, Germany.; Bukur T; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University gGmbH, 55131 Mainz, Germany.; Schrörs B; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University gGmbH, 55131 Mainz, Germany.; Löewer M; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University gGmbH, 55131 Mainz, Germany.; Diken M; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University gGmbH, 55131 Mainz, Germany.; Türeci Ö; BioNTech SE, 55131 Mainz, Germany.; Sahin U; BioNTech SE, 55131 Mainz, Germany.; Research Center for Immunotherapy (FZI) of the University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.; Kreiter S; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University gGmbH, 55131 Mainz, Germany.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Electronic Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology

Muik A; BioNTech SE, Mainz, Germany.; Adams 3rd HC; Genmab US Inc, Plainsboro, New Jersey, USA.; Gieseke F; BioNTech SE, Mainz, Germany.; Altintas I; Translational Research and Precision Medicine, Genmab BV, Utrecht, The Netherlands.; Schoedel KB; BioNTech SE, Mainz, Germany.; Blum JM; Genmab US Inc, Plainsboro, New Jersey, USA.; Sänger B; BioNTech SE, Mainz, Germany.; Burm SM; Translational Research and Precision Medicine, Genmab BV, Utrecht, The Netherlands.; Stanganello E; TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Mainz, Germany.; Verzijl D; Translational Research and Precision Medicine, Genmab BV, Utrecht, The Netherlands.; Spires VM; Genmab US Inc, Plainsboro, New Jersey, USA.; Vascotto F; TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Mainz, Germany.; Toker A; BioNTech SE, Mainz, Germany.; Quinkhardt J; BioNTech SE, Mainz, Germany.; Fereshteh M; Genmab US Inc, Plainsboro, New Jersey, USA.; Diken M; BioNTech SE, Mainz, Germany.; Satijn DPE; Genmab BV, Utrecht, The Netherlands.; Kreiter S; BioNTech SE, Mainz, Germany.; Ahmadi T; Experimental Medicine, Genmab US Inc, Plainsboro, New Jersey, USA.; Breij ECW; Translational Research and Precision Medicine, Genmab BV, Utrecht, The Netherlands.; Türeci Ö; BioNTech SE, Mainz, Germany.; Sasser K; Genmab US Inc, Plainsboro, New Jersey, USA.; Sahin U; BioNTech SE, Mainz, Germany.; TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Mainz, Germany.; Jure-Kunkel M; Genmab US Inc, Plainsboro, New Jersey, USA mjk@genmab.com.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Muik A; BioNTech, Mainz, Germany.; Garralda E; Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain.; Altintas I; Genmab B.V., Utrecht, the Netherlands.; Gieseke F; BioNTech, Mainz, Germany.; Geva R; Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Ben-Ami E; Department of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel.; Maurice-Dror C; Institute of Oncology, Rambam Health Care Campus, Haifa, Israel.; Calvo E; START Madrid-CIOCC, Clara Campal Comprehensive Cancer Center, Madrid, Spain.; LoRusso PM; Yale Cancer Center, Yale University, New Haven, Connecticut.; Alonso G; Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain.; Rodriguez-Ruiz ME; Radiation Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain.; Schoedel KB; BioNTech, Mainz, Germany.; Blum JM; Genmab U.S. Inc., Princeton, New Jersey.; Sänger B; BioNTech, Mainz, Germany.; Salcedo TW; Genmab U.S. Inc., Princeton, New Jersey.; Burm SM; Genmab B.V., Utrecht, the Netherlands.; Stanganello E; TRON gGmbH, Translational Oncology at the University Medical Center of the Johannes Gutenberg University, Mainz, Germany.; Verzijl D; Genmab B.V., Utrecht, the Netherlands.; Vascotto F; TRON gGmbH, Translational Oncology at the University Medical Center of the Johannes Gutenberg University, Mainz, Germany.; Sette A; Genmab B.V., Utrecht, the Netherlands.; Quinkhardt J; BioNTech, Mainz, Germany.; Plantinga TS; Genmab B.V., Utrecht, the Netherlands.; Toker A; BioNTech, Mainz, Germany.; van den Brink EN; Genmab B.V., Utrecht, the Netherlands.; Fereshteh M; TRON gGmbH, Translational Oncology at the University Medical Center of the Johannes Gutenberg University, Mainz, Germany.; Diken M; BioNTech, Mainz, Germany.; Satijn D; Genmab B.V., Utrecht, the Netherlands.; Kreiter S; BioNTech, Mainz, Germany.; Breij ECW; Genmab B.V., Utrecht, the Netherlands.; Bajaj G; Genmab U.S. Inc., Princeton, New Jersey.; Lagkadinou E; BioNTech, Mainz, Germany.; Sasser K; Genmab U.S. Inc., Princeton, New Jersey.; Türeci Ö; BioNTech, Mainz, Germany.; Forssmann U; Genmab A/S, Copenhagen, Denmark.; Ahmadi T; Genmab U.S. Inc., Princeton, New Jersey.; Şahin U; BioNTech, Mainz, Germany.; Jure-Kunkel M; Genmab U.S. Inc., Princeton, New Jersey.; Melero I; Department of Immunology, Clínica Universidad de Navarra and CIBERONC, Pamplona, Spain.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Sahin U; BioNTech, Mainz, Germany. ugur.sahin@biontech.de.; TRON, Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany. ugur.sahin@biontech.de.; Research Center for Immunotherapy (FZI), University Medical Center at the Johannes Gutenberg University Mainz, Mainz, Germany. ugur.sahin@biontech.de.; HI-TRON, Helmholtz Institute for Translational Oncology Mainz - A Helmholtz Institute of the DKFZ, Mainz, Germany. ugur.sahin@biontech.de.; Oehm P; BioNTech, Mainz, Germany.; Derhovanessian E; BioNTech, Mainz, Germany.; Jabulowsky RA; BioNTech, Mainz, Germany.; Vormehr M; BioNTech, Mainz, Germany.; Gold M; BioNTech, Mainz, Germany.; Maurus D; BioNTech, Mainz, Germany.; Schwarck-Kokarakis D; BioNTech, Mainz, Germany.; Kuhn AN; BioNTech, Mainz, Germany.; Omokoko T; BioNTech, Mainz, Germany.; Kranz LM; BioNTech, Mainz, Germany.; Diken M; BioNTech, Mainz, Germany.; TRON, Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.; Kreiter S; BioNTech, Mainz, Germany.; TRON, Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.; Haas H; BioNTech, Mainz, Germany.; Attig S; TRON, Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.; Research Center for Immunotherapy (FZI), University Medical Center at the Johannes Gutenberg University Mainz, Mainz, Germany.; Rae R; TRON, Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.; Cuk K; BioNTech, Mainz, Germany.; Kemmer-Brück A; BioNTech, Mainz, Germany.; Breitkreuz A; BioNTech, Mainz, Germany.; Tolliver C; BioNTech, Mainz, Germany.; Caspar J; BioNTech, Mainz, Germany.; Quinkhardt J; BioNTech, Mainz, Germany.; Hebich L; BioNTech, Mainz, Germany.; Stein M; BioNTech, Mainz, Germany.; Hohberger A; TRON, Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.; Vogler I; BioNTech, Mainz, Germany.; Liebig I; BioNTech, Mainz, Germany.; Renken S; BioNTech, Mainz, Germany.; Sikorski J; BioNTech, Mainz, Germany.; Leierer M; Department of Dermatology and National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany.; Müller V; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Mannheim, Germany.; Mitzel-Rink H; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.; Miederer M; Department of Nuclear Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.; Huber C; BioNTech, Mainz, Germany.; TRON, Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.; Grabbe S; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.; Utikal J; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Mannheim, Germany.; Pinter A; Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany.; Kaufmann R; Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany.; Hassel JC; Department of Dermatology and National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany.; Loquai C; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.; Türeci Ö; BioNTech, Mainz, Germany.; HI-TRON, Helmholtz Institute for Translational Oncology Mainz - A Helmholtz Institute of the DKFZ, Mainz, Germany.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Kalaora S; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Wolf Y; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Feferman T; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.; Barnea E; Department of Biology, Technion, Haifa, Israel.; Greenstein E; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.; Reshef D; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.; Tirosh I; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Reuben A; Departments of Surgical Oncology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Patkar S; Cancer Data Science Lab, National Cancer Institute, NIH, Rockville, Maryland.; Levy R; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Quinkhardt J; BioNTech Cell & Gene Therapies GmbH, Mainz, Germany.; Omokoko T; BioNTech Cell & Gene Therapies GmbH, Mainz, Germany.; Qutob N; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Golani O; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.; Zhang J; Departments of Surgical Oncology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Mao X; Departments of Surgical Oncology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Song X; Departments of Surgical Oncology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Haymaker C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Forget MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Creasy C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Greenberg P; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Carter BW; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Cooper ZA; Departments of Surgical Oncology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Rosenberg SA; National Cancer Institute, NIH, Maryland.; Lotem M; Sharett Institute of Oncology, Hadassah Medical School, Jerusalem, Israel.; Sahin U; TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University GmbH, Mainz, Germany.; Shakhar G; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.; Ruppin E; Cancer Data Science Lab, National Cancer Institute, NIH, Rockville, Maryland.; Wargo JA; Departments of Surgical Oncology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Friedman N; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.; Admon A; Department of Biology, Technion, Haifa, Israel.; Samuels Y; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. yardena.samuels@weizmann.ac.il.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Loquai, Carmen; Hassel, Jessica; Brueck, Patrick; Derhovanessian, Evelyna; Cuk, Katarina; Loeks, Verena; Sikorski, Julian; Gold, Maike; Maurus, Daniel; Schwarck-Kokarakis, Doreen; Kaestner, Marion; Weisenburger, Thomas; Eller, Ann-Kathrin; Attig, Sebastian; Hempel, Silvana; Oehm, Petra; Omokoko, Tana; Kranz, Lena; Quinkhardt, Juliane; Vogler, Isabel; Liebig, Inga; Renken, Stephanie; Leierer, Melanie; Mueller, Verena; Mitzel-Rink, Heidrun; Miederer, Matthias; Grabbe, Stephan; Utikal, Jochen; Kaufmann, Roland; Sahin, Ugur; Tuereci, Oezlem

JOURNAL FOR IMMUNOTHERAPY OF CANCER; NOV 2021, 9 pA579-pA579, 1p. Supplement: 2